Atlas Trials

Ex Vivo Drug Response Profiling and Outcome Prediction in Lung Adenocarcinoma

Clinical trial NCT07636252 · RECRUITING

Trial details

NCT number
NCT07636252
Sponsor
Sheba Medical Center
Status
RECRUITING
Study type
OBSERVATIONAL
Lung AdenocarcinomaMalignant Pleural Effusions (Mpe)
Start date
2023-06-14
Primary completion
2028-12-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.